Industrials·Industrial Machinery & Supplies & Components·$29.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.47 | N/A | +2.40% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.47 | N/A | +2.40% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a cautious optimism about the company's performance. They acknowledged market challenges but emphasized their commitment to operational improvements.
Management highlighted ongoing operational improvements.
They noted challenges in the market but expressed confidence in long-term strategies.
Xylem's earnings report showed a slight beat on EPS, which indicates some positive performance despite a lack of revenue data. However, the stock reacted negatively, dropping 3.38%, likely due to the absence of revenue figures and forward guidance. Investors may be concerned about market challenges mentioned by management.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
EDWARDS LIFESCIENCES
Feb 4, 2013